Company: NEOG
Filing Date: 2025-01-15
Form Type: 10-Q
Source: 0000950170-25-005818
Chunk: 2

Company: NEOGEN CORP
Filing Date: 2025-01-15
Form: 10-Q
Item: Item 1
Chunk 2
---

    Other current liabilities

    24,647

    22,800

    Total Current Liabilities

    151,195

    154,323

    Deferred Income Tax Liability

    302,405

    326,718

    Non-Current Debt

    889,867

    888,391

    Other Non-Current Liabilities

    41,555

    35,259

    Total Liabilities

    1,385,022

    1,404,691

    Commitments and Contingencies (note 8)

    Equity

    Preferred stock, $1.00 par value, 100,000 shares authorized, none issued and outstanding

    -

    -

    Common stock, $0.16 par value, 315,000,000 shares authorized, 216,944,017 and 216,614,407 shares issued and outstanding

    34,712

    34,658

    Additional paid-in capital

    2,592,374

    2,583,885

    Accumulated other comprehensive loss

    (44,745
    )

    (30,021
    )

    Retained earnings

    86,729

    555,620

    Total Stockholders’ Equity

    2,669,070

    3,144,142

    Total Liabilities and Stockholders’ Equity
     
    $
    4,054,092

    $
    4,548,833

2

The accompanying notes are an integral part of these condensed consolidated financial statements.

Neogen Corporation

Condensed Consolidated Statements of Operations (unaudited) 

(in thousands, except shares) 

    Three months ended November 30,

    Six months ended November 30,

    2024

    2023

    2024

    2023

    Revenues

    Product revenues
     
    $
    207,549

    $
    203,869

    $
    400,067

    $
    408,270

    Service revenues

    23,709

    25,760

    48,155

    50,346

    Total Revenues

    231,258

    229,629

    448,222

    458,616

    Cost of Revenues

    Cost